Tatva Chintan Pharma

Tatva Chintan Pharma

1,145.75
+130.30
(12.83%)
Market Cap
2,375.30 Cr
EPS
2.44
PE Ratio
332.22
Dividend Yield
0.10 %
Industry
Chemicals
52 Week High
1,102.00
52 Week Low
621.00
PB Ratio
3.22
Debt to Equity
0.15
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+60.00 %
+60.00 %
Hold
Hold+20.00 %
+20.00 %
Sell
Sell+20.00 %
+20.00 %

Company News

View All News
Caret
positive
Tatva Chintan Pharma Chem Ltd. shares jumped nearly 20% to reach a 52-week high of ₹1,218.5 following strong quarterly performance. The company reported a 27.7% increase in profit after tax to ₹6.7 crore, while revenue grew 10.8% to ₹117 crore. EBITDA expanded 37.4% to ₹17 crore, with operating margins improving to 14.8% from 12% in the previous year. The stock also gained momentum after Mukul Agrawal acquired a 1.28% stake in the company. Promoters hold 72% of the company at the end of the June quarter. The stock has gained 27% in the past month and 39.11% year-to-date.
positive
Tatva Chintan is experiencing strong growth supported by its leadership in green chemistry, expanded manufacturing capacity, and increasing global demand for specialty chemicals. The company operates across three key segments: PTC (Phase Transfer Catalysts), SDA (Structural Directing Agents), and battery materials, all of which are benefiting from rising international demand for niche specialty chemicals.
neutral
Tatva Chintan Pharma Chem Limited announced its unaudited financial results for the quarter ended June 30, 2025. The company reported consolidated revenue from operations of Rs 1,168.64 million and net profit of Rs 57.13 million for the quarter. The board approved reappointments of three key directors - Managing Director Chintan Nitinkumar Shah, and Whole-time Directors Ajaykumar Mansukhlal Patel and Shekhar Rasiklal Somani - for one-year terms from February 1, 2026 to January 31, 2027. Additionally, three Independent Directors - Subhash Ambubhai Patel, Manher Chimanlal Desai, and Avani Rajesh Umatt - were reappointed for five-year terms from February 27, 2026 to February 26, 2031. All reappointments are subject to shareholder approval at the upcoming Annual General Meeting. The company also announced the resignation of Chief Financial Officer Ashok Bothra, effective August 30, 2025, citing personal and professional goals as reasons for his departure.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,889.60
#1 1,47,910.00
70.62
13,387.50
5.69
#1 2,096
40.49
32.04
3,040.80
93,385.70
65.14
14,825.80
12.13
1,251
71.41
39.05
3,508.90
39,285.70
71.82
4,737.00
-25.09
523
#1 89.11
47.36
1,902.60
26,225.70
#1 37.60
8,281.93
-3.26
724
-20.24
36.75
498.35
25,334.50
41.23
4,664.30
10.33
555
46.09
50.59
5,003.40
25,171.50
90.03
2,393.10
0.37
289
34.94
56.98
5,045.00
22,300.80
48.73
#1 15,339.40
-
479
-83.27
48.40
1,868.80
19,700.60
48.64
2,248.17
-8.77
424
18.04
39.85
6,667.00
19,430.10
38.90
5,692.40
#1 18.99
499
18.11
33.60
5,194.50
16,513.50
40.17
2,269.15
-28.91
409
-15.27
53.37
Forecast
Actual
Growth Rate
Revenue Growth
-6.61 %
Net Income Growth
-33.19 %
Cash Flow Change
252.92 %
ROE
-53.39 %
ROCE
-33.66 %
EBITDA Margin (Avg.)
22.20 %

Quarterly Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
52
62
81
111
109
127
109
99
90
92
122
125
115
97
85
103
107
84
86
109
118
Expenses
41
54
56
84
81
88
81
77
73
79
103
112
93
76
73
83
93
78
79
99
100
EBITDA
11
8
25
27
28
39
29
22
17
13
19
14
22
21
12
20
14
6
7
10
19
Operating Profit %
20 %
11 %
31 %
23 %
24 %
29 %
23 %
22 %
17 %
12 %
15 %
10 %
19 %
21 %
13 %
16 %
12 %
7 %
8 %
8 %
15 %
Depreciation
2
2
2
2
2
2
2
2
2
2
2
3
6
7
7
6
7
7
7
7
9
Interest
1
1
1
1
1
1
1
1
1
1
2
3
3
3
0
0
0
0
0
0
0
Profit Before Tax
8
6
23
24
24
35
26
19
14
9
14
8
13
11
5
14
7
-1
-0
2
9
Tax
2
2
2
3
1
3
3
2
4
2
3
-9
4
3
2
4
2
-0
-0
1
3
Net Profit
7
4
21
21
23
32
23
18
10
7
12
17
10
8
4
10
5
-1
0
1
7
EPS in ₹
3.34
1.77
10.39
10.51
11.52
15.02
10.29
7.90
4.42
3.21
5.24
7.65
4.29
3.43
1.48
4.11
2.23
-0.29
0.06
0.44
2.84

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
144
188
249
315
658
759
819
836
Fixed Assets
57
67
111
120
160
196
427
553
Current Assets
77
114
133
184
436
312
298
265
Capital Work in Progress
10
6
5
10
52
231
77
22
Investments
1
0
0
0
0
0
10
134
Other Assets
76
115
133
185
447
332
305
0
Total Liabilities
144
188
249
315
658
759
819
836
Current Liabilities
63
73
88
118
171
239
80
96
Non Current Liabilities
22
35
44
31
14
5
2
1
Total Equity
59
80
118
166
473
515
737
739
Reserve & Surplus
51
72
110
146
451
493
714
715
Share Capital
8
8
8
20
22
22
23
23

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-10
8
-5
-6
59
-36
8
Investing Activities
-30
-17
-40
-21
-197
-101
-121
Operating Activities
13
7
25
20
20
28
98
Financing Activities
7
17
10
-5
235
38
31

Share Holding

% Holding
Jul 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
79.17 %
75.02 %
72.02 %
72.02 %
72.02 %
72.02 %
72.02 %
72.02 %
72.02 %
72.02 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.41 %
4.21 %
3.65 %
3.37 %
3.33 %
3.36 %
3.30 %
3.26 %
DIIs
5.52 %
7.36 %
7.78 %
7.95 %
10.56 %
11.16 %
11.52 %
11.71 %
11.07 %
13.68 %
13.79 %
13.06 %
12.84 %
10.63 %
6.82 %
6.34 %
5.46 %
5.11 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.89 %
6.44 %
6.62 %
6.35 %
6.03 %
5.49 %
5.01 %
5.09 %
5.91 %
6.23 %
8.72 %
9.38 %
10.49 %
12.44 %
15.95 %
16.33 %
16.92 %
17.47 %
Others
5.42 %
7.03 %
6.43 %
6.53 %
4.24 %
4.19 %
4.31 %
4.03 %
3.85 %
5.07 %
1.06 %
1.33 %
1.00 %
1.54 %
1.87 %
1.95 %
2.30 %
2.14 %
No of Share Holders
11
89,438
88,311
89,930
84,358
76,267
71,958
70,037
70,799
71,340
74,628
74,519
73,730
73,912
79,623
79,009
78,393
76,792

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 5 2 2 2 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.22 0.12 0.19 0.3 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jul 2025 944.95 997.40
02 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 May 2025 761.40 706.00
28 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2025 843.90 814.75
25 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Oct 2024 1,002.00 949.30
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 1,000.80 972.05
07 Sept 2024 DIVIDEND Dividend
₹ 2.00 /share
06 Sept 2024 1,228.15 972.95
08 Sept 2023 DIVIDEND Dividend
₹ 2.00 /share
08 Sept 2023 1,835.95 1,636.45
09 Sept 2022 DIVIDEND Dividend
₹ 2.00 /share
08 Sept 2022 2,478.80 2,480.20

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
Announcement under Regulation 30 (LODR)-Investor Presentation2 days ago
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)2 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate2 days ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On 24.07.20252 days ago
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended 30 June 20252 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 24.07.20258 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 05, 2025
Closure of Trading WindowJun 25, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJun 17, 2025
Clarification On Price MovementMay 23, 2025
Clarification sought from Tatva Chintan Pharma Chem LtdMay 22, 2025
Clarification On Increase / Spurt In VolumeMay 21, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 05, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 03, 2025
Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended On 31 March 2025May 02, 2025
Appointment Of Secretarial Auditor Cost Auditor And Internal AuditorMay 02, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 02, 2025
Corporate Action-Board approves DividendMay 02, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 02.05.2025May 02, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 29, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 25, 2025
Board Meeting Intimation for Board Meeting Intimation For Intimation Of Board Meeting To Be Held On Friday 02.05.2025Apr 25, 2025
Intimation Of Change In Contact Details Of MUFG Intime India Private Limited Registrar And Share Transfer Agent (RTA) Of The Company.Apr 19, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 28, 2025
Integrated Filing (Financial)Jan 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 28, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 28.01.2025Jan 28, 2025
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended On 31 December 2024Jan 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 17, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 28.01.2025Jan 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Intimation For Change Of Name Of Registrar And Share Transfer Agent (RTA) Of The Company.Jan 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 04, 2024
Announcement under Regulation 30 (LODR)-Credit RatingNov 06, 2024

Technical Indicators

RSI(14)
Neutral
73.71
ATR(14)
Volatile
53.01
STOCH(9,6)
Neutral
67.33
STOCH RSI(14)
Neutral
71.50
MACD(12,26)
Bullish
11.68
ADX(14)
Strong Trend
30.86
UO(9)
Bearish
51.34
ROC(12)
Uptrend And Accelerating
19.79
WillR(14)
Neutral
-24.35

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Smallcap Fund Direct Plan-Growth
0.22%
-39457
-0.04%
-0.02%
Nippon India ELSS Tax Saver Fund Direct-Growth
0.47%
-4910
0.01%
0.10%
ICICI Prudential Commodities Fund Direct - Growth
0.19%
0
0.00%
0.03%
ICICI Prudential MNC Fund Direct - Growth
0.95%
0
0.05%
0.22%
Nippon India Small Cap Fund Direct- Growth
0.00%
0
0.00%
0.00%
SBI Mid Cap Direct Plan-Growth
0.00%
0
0.00%
0.00%